Using bacteria to improve cancer treatment
Improving bacterial cancer therapeutics
This study is looking at how specially modified bacteria can be used to deliver cancer treatments right to tumors, with the hope of making the treatments work better and cause fewer side effects for people with cancer.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11112287 on NIH RePORTER |
What this research studies
This research explores the use of genetically modified bacteria as a novel approach to deliver cancer therapies directly to tumors. By understanding how these bacteria can selectively colonize tumor tissue, the study aims to enhance their effectiveness and reduce side effects associated with traditional cancer treatments. The research involves comprehensive screening to identify the mechanisms that allow bacteria to target tumors, which could lead to improved therapeutic strategies for patients with cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with specific types of cancer who may benefit from innovative therapeutic approaches.
Not a fit: Patients who do not have cancer or those whose cancer is not amenable to bacterial therapy may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and targeted cancer treatments with fewer side effects for patients.
How similar studies have performed: While bacterial cancer therapy has historical precedent, this research aims to explore novel mechanisms and has the potential to uncover new pathways that have not been extensively studied before.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Chen, Noah — Columbia University Health Sciences
- Study coordinator: Chen, Noah
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.